Knight Capital Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Knight Capital Group’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$496K	Buy	+13,241	New	+$523K	0.01%	1712

Other funds holding MR

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TGA

Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Knight Capital Group's MR Position: Q2 2013 in Review

Knight Capital Group opened a new position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2013: 13,241 shares worth $496K. The stake represents 0.01% of the portfolio and ranks #1712 among its holdings.

161 funds tracked by Wall St. Rank hold MR as of Q2 2013.

Knight Capital Group held 13,241 shares of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A worth $496K as of Q2 2013.
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A was a new Knight Capital Group position in Q2 2013.
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #1712 holding.
161 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.